Washington, D.C. – The American Clinical Laboratory Association (ACLA) today issued the following statement as the federal government’s formal declaration of a Public Health Emergency (PHE) ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) released the following statement in response to the Biden-Harris Administration designating fentanyl-xylazine as an emerging threat: “The ... Read More
Washington D.C. – The American Clinical Laboratory Association (ACLA) released the following statement in response to a Texas court striking down an Affordable Care Act (ACA) provision ... Read More
Association Relaunches ‘Stop Lab Cuts’ Campaign Washington, D.C. – The American Clinical Laboratory Association (ACLA) today welcomed the bipartisan and bicameral introduction of the Saving ... Read More
The 2023 Omnibus provides critical relief for labs and patients Washington, D.C. – The American Clinical Laboratory Association (ACLA) commends inclusion in the 2023 Omnibus Appropriations Bill ... Read More
Washington, D.C. – In response to the Senate Committee on Health, Education, Labor and Pensions’ (HELP) release of a bipartisan, updated version of the Verifying Accurate Leading-edge IVCT ... Read More